WHO ICTRP trial
Old medicine for new use:Multicenter prospective cohort study of the effect of…
ChiCTR2500105183 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500105183 |
|---|---|
| Public title | Old medicine for new use:Multicenter prospective cohort study of the effect of hydroxychloroquine on pregnancy outcomes in patients with unexplained recurrent spontaneous abortion complicated with antinuclear antibody positivity |
| Scientific title | Old medicine for new use:Multicenter prospective cohort study of the effect of hydroxychloroquine on pregnancy outcomes in patients with unexplained recurrent spontaneous abortion complicated with antinuclear antibody positivity |
| Primary sponsor | Peking University Third Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | recurrent spontaneous abortion |
| Interventions | aspirin group :NA;Hydroxychloroquine group :NA |
| Registration date | Jun 30, 2025 |
| Target size | aspirin group :360;Hydroxychloroquine group :360 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: